Real-world evidence of sorafenib for the treatment of hepatocellular carcinoma: A single-center study
{{output}}
Context: Hepatocellular carcinoma is the third leading cause of cancer death. Currently, sorafenib is the treatment of choice in advanced hepatocarcinoma. Aims: ... ...
